Why TPRM matters
Our success depends on strong, reliable and reputable partners. They help us build trust with our stakeholders by living up to the same standards as ours.
Novartis is a member of the Pharmaceutical Supply Chain Initiative (PSCI). Our Third Party Code is also consistent with the PSCI Principles for Responsible Supply Chain Management for ethics, human rights, labor rights, health and safety, environment and related management systems. The PSCI was formed as a non-profit business membership organization in 2006. It brings together the pharmaceutical industry to define, implement and champion responsible supply chain practices, and aims to help suppliers meet the industry’s expectations.
In addition, risk experts from different TPRM risk areas participate in PSCI working groups, help to promote PSCI principles and evolve thinking with peers from other pharmaceutical companies.
For example, we actively participate in the shared audit program and working committees. Novartis also sits on the PSCI Board.
The shared audit program enables suppliers to share audits with more than one PSCI member via a web-based platform. This means fewer audits for each supplier and reduced costs and efficiency gains for PSCI members. Each year, Novartis encourages its suppliers to share audit reports on the PSCI platform.
Working committees in PSCI cover Audit, Communication, Governance, Supplier capability and Partnership. All committees have different sub-teams in which Novartis actively participates to build supplier knowledge and expertise and help solve safety, social, environmental and ethical issues.
Novartis actively shares guidance and resources in PSCI supplier conferences and webinars. Each year, we engage PSCI members, suppliers and expert organizations by participating in supplier conferences hosted in some of the most important sourcing regions.